
Ferdi Steinmann looks at pharma's current relationship with AI and how it is set to evolve.
With nearly 25 years of experience in driving strategy & commercialization efforts in Biotech & Pharma, with an exclusive focus in Life Sciences (LS) strategic planning and industry marketing efforts for enterprise software solutions, Ferdi Steinmann is responsible for the LS global industry strategy development at OpenText.
Published: August 31st 2020 | Updated: